PolyNovo (ASX:PNV) has announced that Professor Toby Coates AO, the director of Beta Cell Technologies, has presented the results of the company's NovoSorb and its potential role in treating and managing Type 1 diabetes.
News
New Stories
-
PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes
May 14, 2025 - - AusBiotech -
Amplia reports updated positive data from ACCENT trial in pancreatic cancer
May 14, 2025 - - Latest News -
Immutep’s efti with PD-L1 and chemotherapy achieves high response rates in lung cancer
May 14, 2025 - - Latest News -
CSL Behring wins major international pharmaceutical engineering award
May 14, 2025 - - Latest News -
Lumos advances FebriDx sales with iMedical purchase order
May 14, 2025 - - Latest News -
PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes
May 14, 2025 - - Latest News -
EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy
May 12, 2025 - - Latest News